4ekw › Citations

Crystal structure of a voltage-gated sodium channel in two potentially inactivated states.

Payandeh J, Gamal El-Din TM, Scheuer T, Zheng N, Catterall WA
Nature 486 135-9 (2012)
Cited: 307 times
EuropePMC logo PMID: 22678296

Abstract

In excitable cells, voltage-gated sodium (Na(V)) channels activate to initiate action potentials and then undergo fast and slow inactivation processes that terminate their ionic conductance. Inactivation is a hallmark of Na(V) channel function and is critical for control of membrane excitability, but the structural basis for this process has remained elusive. Here we report crystallographic snapshots of the wild-type Na(V)Ab channel from Arcobacter butzleri captured in two potentially inactivated states at 3.2 Å resolution. Compared to previous structures of Na(V)Ab channels with cysteine mutations in the pore-lining S6 helices (ref. 4), the S6 helices and the intracellular activation gate have undergone significant rearrangements: one pair of S6 helices has collapsed towards the central pore axis and the other S6 pair has moved outward to produce a striking dimer-of-dimers configuration. An increase in global structural asymmetry is observed throughout our wild-type Na(V)Ab models, reshaping the ion selectivity filter at the extracellular end of the pore, the central cavity and its residues that are analogous to the mammalian drug receptor site, and the lateral pore fenestrations. The voltage-sensing domains have also shifted around the perimeter of the pore module in wild-type Na(V)Ab, compared to the mutant channel, and local structural changes identify a conserved interaction network that connects distant molecular determinants involved in Na(V) channel gating and inactivation. These potential inactivated-state structures provide new insights into Na(V) channel gating and novel avenues to drug development and therapy for a range of debilitating Na(V) channelopathies.

Reviews - 4ekw mentioned but not cited (7)

  1. Structure of potassium channels. Kuang Q, Purhonen P, Hebert H. Cell Mol Life Sci 72 3677-3693 (2015)
  2. Bacterial voltage-gated sodium channels (BacNa(V)s) from the soil, sea, and salt lakes enlighten molecular mechanisms of electrical signaling and pharmacology in the brain and heart. Payandeh J, Minor DL. J Mol Biol 427 3-30 (2015)
  3. Structural model of the open-closed-inactivated cycle of prokaryotic voltage-gated sodium channels. Bagnéris C, Naylor CE, McCusker EC, Wallace BA. J Gen Physiol 145 5-16 (2015)
  4. Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity. Green BR, Bulaj G, Norton RS. Future Med Chem 6 1677-1698 (2014)
  5. Sodium Channels and Local Anesthetics-Old Friends With New Perspectives. Körner J, Albani S, Sudha Bhagavath Eswaran V, Roehl AB, Rossetti G, Lampert A. Front Pharmacol 13 837088 (2022)
  6. K(+) and Na(+) conduction in selective and nonselective ion channels via molecular dynamics simulations. Furini S, Domene C. Biophys J 105 1737-1745 (2013)
  7. Proton channel models filling the gap between experimental data and the structural rationale. Pupo A, Baez-Nieto D, Martínez A, Latorre R, González C. Channels (Austin) 8 180-192 (2014)

Articles - 4ekw mentioned but not cited (38)



Reviews citing this publication (81)

  1. The hitchhiker's guide to the voltage-gated sodium channel galaxy. Ahern CA, Payandeh J, Bosmans F, Bosmans F, Chanda B. J Gen Physiol 147 1-24 (2016)
  2. Neurological perspectives on voltage-gated sodium channels. Eijkelkamp N, Linley JE, Baker MD, Minett MS, Cregg R, Werdehausen R, Rugiero F, Wood JN. Brain 135 2585-2612 (2012)
  3. Emerging Diversity in Lipid-Protein Interactions. Corradi V, Sejdiu BI, Mesa-Galloso H, Abdizadeh H, Noskov SY, Marrink SJ, Tieleman DP. Chem Rev 119 5775-5848 (2019)
  4. Discovery, synthesis, and structure-activity relationships of conotoxins. Akondi KB, Muttenthaler M, Dutertre S, Kaas Q, Craik DJ, Lewis RJ, Alewood PF. Chem Rev 114 5815-5847 (2014)
  5. Structure and function of voltage-gated sodium channels at atomic resolution. Catterall WA. Exp Physiol 99 35-51 (2014)
  6. The chemical basis for electrical signaling. Catterall WA, Wisedchaisri G, Zheng N. Nat Chem Biol 13 455-463 (2017)
  7. From foe to friend: using animal toxins to investigate ion channel function. Kalia J, Milescu M, Salvatierra J, Wagner J, Klint JK, King GF, Olivera BM, Bosmans F, Bosmans F. J Mol Biol 427 158-175 (2015)
  8. Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels. Catterall WA, Swanson TM. Mol Pharmacol 88 141-150 (2015)
  9. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C. Epilepsy Res 110 189-205 (2015)
  10. Membrane Protein Structure, Function, and Dynamics: a Perspective from Experiments and Theory. Cournia Z, Allen TW, Andricioaei I, Antonny B, Baum D, Brannigan G, Buchete NV, Deckman JT, Delemotte L, Del Val C, Friedman R, Gkeka P, Hege HC, Hénin J, Kasimova MA, Kolocouris A, Klein ML, Khalid S, Lemieux MJ, Lindow N, Roy M, Selent J, Tarek M, Tofoleanu F, Vanni S, Urban S, Wales DJ, Smith JC, Bondar AN. J Membr Biol 248 611-640 (2015)
  11. Recent progress in sodium channel modulators for pain. Bagal SK, Chapman ML, Marron BE, Prime R, Storer RI, Swain NA. Bioorg Med Chem Lett 24 3690-3699 (2014)
  12. Non-covalent binding of membrane lipids to membrane proteins. Yeagle PL. Biochim Biophys Acta 1838 1548-1559 (2014)
  13. Distribution and function of voltage-gated sodium channels in the nervous system. Wang J, Ou SW, Wang YJ. Channels (Austin) 11 534-554 (2017)
  14. Voltage-Gated Potassium Channels: A Structural Examination of Selectivity and Gating. Kim DM, Nimigean CM. Cold Spring Harb Perspect Biol 8 a029231 (2016)
  15. Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias. Herren AW, Bers DM, Grandi E. Am J Physiol Heart Circ Physiol 305 H431-45 (2013)
  16. Voltage gated sodium channels as drug discovery targets. Bagal SK, Marron BE, Owen RM, Storer RI, Swain NA. Channels (Austin) 9 360-366 (2015)
  17. Biophysics, pathophysiology, and pharmacology of ion channel gating pores. Moreau A, Gosselin-Badaroudine P, Chahine M. Front Pharmacol 5 53 (2014)
  18. Saxitoxin. Thottumkara AP, Parsons WH, Du Bois J. Angew Chem Int Ed Engl 53 5760-5784 (2014)
  19. The dual-gate model for pentameric ligand-gated ion channels activation and desensitization. Gielen M, Corringer PJ. J Physiol 596 1873-1902 (2018)
  20. Voltage-gated sodium channels and cancer: is excitability their primary role? Roger S, Gillet L, Le Guennec JY, Besson P. Front Pharmacol 6 152 (2015)
  21. Ion channels as drug targets in central nervous system disorders. Waszkielewicz AM, Gunia A, Szkaradek N, Słoczyńska K, Krupińska S, Marona H. Curr Med Chem 20 1241-1285 (2013)
  22. Na+ channel function, regulation, structure, trafficking and sequestration. Chen-Izu Y, Shaw RM, Pitt GS, Yarov-Yarovoy V, Sack JT, Abriel H, Aldrich RW, Belardinelli L, Cannell MB, Catterall WA, Chazin WJ, Chiamvimonvat N, Deschenes I, Grandi E, Hund TJ, Izu LT, Maier LS, Maltsev VA, Marionneau C, Mohler PJ, Rajamani S, Rasmusson RL, Sobie EA, Clancy CE, Bers DM. J Physiol 593 1347-1360 (2015)
  23. Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review. Menezes LFS, Sabiá Júnior EF, Tibery DV, Carneiro LDA, Schwartz EF. Front Pharmacol 11 1276 (2020)
  24. Ion channels and ion selectivity. Roux B. Essays Biochem 61 201-209 (2017)
  25. The Hodgkin-Huxley heritage: from channels to circuits. Catterall WA, Raman IM, Robinson HP, Sejnowski TJ, Paulsen O. J Neurosci 32 14064-14073 (2012)
  26. Functional and structural dynamics of NhaA, a prototype for Na(+) and H(+) antiporters, which are responsible for Na(+) and H(+) homeostasis in cells. Padan E. Biochim Biophys Acta 1837 1047-1062 (2014)
  27. The structure and regulation of magnesium selective ion channels. Payandeh J, Pfoh R, Pai EF. Biochim Biophys Acta 1828 2778-2792 (2013)
  28. Animal toxins influence voltage-gated sodium channel function. Gilchrist J, Olivera BM, Bosmans F, Bosmans F. Handb Exp Pharmacol 221 203-229 (2014)
  29. Sodium channelopathies of skeletal muscle and brain. Mantegazza M, Cestèle S, Catterall WA. Physiol Rev 101 1633-1689 (2021)
  30. The pharmacology of voltage-gated sodium channel activators. Deuis JR, Mueller A, Israel MR, Vetter I. Neuropharmacology 127 87-108 (2017)
  31. Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics? Knapp O, McArthur JR, Adams DJ. Toxins (Basel) 4 1236-1260 (2012)
  32. An Update on the Structure of hERG. Butler A, Helliwell MV, Zhang Y, Hancox JC, Dempsey CE. Front Pharmacol 10 1572 (2019)
  33. Advances in targeting voltage-gated sodium channels with small molecules. Nardi A, Damann N, Hertrampf T, Kless A. ChemMedChem 7 1712-1740 (2012)
  34. Alkaliphilic Bacteria with Impact on Industrial Applications, Concepts of Early Life Forms, and Bioenergetics of ATP Synthesis. Preiss L, Hicks DB, Suzuki S, Meier T, Krulwich TA. Front Bioeng Biotechnol 3 75 (2015)
  35. Deciphering voltage-gated Na(+) and Ca(2+) channels by studying prokaryotic ancestors. Catterall WA, Zheng N. Trends Biochem Sci 40 526-534 (2015)
  36. Conduits of life's spark: a perspective on ion channel research since the birth of neuron. Isacoff EY, Jan LY, Minor DL. Neuron 80 658-674 (2013)
  37. Voltage-gated sodium channels. Kwong K, Carr MJ. Curr Opin Pharmacol 22 131-139 (2015)
  38. Mechanistic Insights into the Modulation of Voltage-Gated Ion Channels by Inhalational Anesthetics. Covarrubias M, Barber AF, Carnevale V, Treptow W, Eckenhoff RG. Biophys J 109 2003-2011 (2015)
  39. Ion channel associated diseases: overview of molecular mechanisms. Zaydman MA, Silva JR, Cui J. Chem Rev 112 6319-6333 (2012)
  40. T-type calcium channels in chronic pain: mouse models and specific blockers. François A, Laffray S, Pizzoccaro A, Eschalier A, Bourinet E. Pflugers Arch 466 707-717 (2014)
  41. Model systems for studying cellular mechanisms of SCN1A-related epilepsy. Schutte SS, Schutte RJ, Barragan EV, O'Dowd DK. J Neurophysiol 115 1755-1766 (2016)
  42. New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles. Beiranvand S, Eatemadi A, Karimi A. Nanoscale Res Lett 11 307 (2016)
  43. Computational studies of marine toxins targeting ion channels. Rashid MH, Mahdavi S, Kuyucak S. Mar Drugs 11 848-869 (2013)
  44. Pharmacological and nutritional targeting of voltage-gated sodium channels in the treatment of cancers. Lopez-Charcas O, Pukkanasut P, Velu SE, Brackenbury WJ, Hales TG, Besson P, Gomora JC, Roger S. iScience 24 102270 (2021)
  45. The conformational cycle of a prototypical voltage-gated sodium channel. Catterall WA, Wisedchaisri G, Zheng N. Nat Chem Biol 16 1314-1320 (2020)
  46. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes. Abdelsayed M, Sokolov S. Channels (Austin) 7 146-152 (2013)
  47. Skeletal muscle sodium channelopathies. Nicole S, Fontaine B. Curr Opin Neurol 28 508-514 (2015)
  48. Venom peptides as a rich source of cav2.2 channel blockers. Sousa SR, Vetter I, Lewis RJ. Toxins (Basel) 5 286-314 (2013)
  49. Computational approaches for designing potent and selective analogs of peptide toxins as novel therapeutics. Kuyucak S, Norton RS. Future Med Chem 6 1645-1658 (2014)
  50. The role of the gap junction perinexus in cardiac conduction: Potential as a novel anti-arrhythmic drug target. Hoagland DT, Santos W, Poelzing S, Gourdie RG. Prog Biophys Mol Biol 144 41-50 (2019)
  51. Basal Ganglia Neuromodulation Over Multiple Temporal and Structural Scales-Simulations of Direct Pathway MSNs Investigate the Fast Onset of Dopaminergic Effects and Predict the Role of Kv4.2. Lindroos R, Dorst MC, Du K, Filipović M, Keller D, Ketzef M, Kozlov AK, Kumar A, Lindahl M, Nair AG, Pérez-Fernández J, Grillner S, Silberberg G, Hellgren Kotaleski J. Front Neural Circuits 12 3 (2018)
  52. Challenges and advances in atomistic simulations of potassium and sodium ion channel gating and permeation. DeMarco KR, Bekker S, Vorobyov I. J Physiol 597 679-698 (2019)
  53. Molecular biology and biophysical properties of ion channel gating pores. Moreau A, Gosselin-Badaroudine P, Chahine M. Q Rev Biophys 47 364-388 (2014)
  54. Structural Advances in Voltage-Gated Sodium Channels. Jiang D, Zhang J, Xia Z. Front Pharmacol 13 908867 (2022)
  55. The voltage-gated sodium channel: a major target of marine neurotoxins. Mattei C, Legros C. Toxicon 91 84-95 (2014)
  56. Voltage Sensing in Membranes: From Macroscopic Currents to Molecular Motions. Freites JA, Tobias DJ. J Membr Biol 248 419-430 (2015)
  57. Polycystin Channel Complexes. Esarte Palomero O, Larmore M, DeCaen PG. Annu Rev Physiol 85 425-448 (2023)
  58. Roles for Countercharge in the Voltage Sensor Domain of Ion Channels. Groome JR, Bayless-Edwards L. Front Pharmacol 11 160 (2020)
  59. Structural and Functional Analyses of Cone Snail Toxins. Morales Duque H, Campos Dias S, Franco OL. Mar Drugs 17 E370 (2019)
  60. Trafficking mechanisms underlying Nav channel subcellular localization in neurons. Solé L, Tamkun MM. Channels (Austin) 14 1-17 (2020)
  61. Voltage-gated sodium channels viewed through a structural biology lens. Clairfeuille T, Xu H, Koth CM, Payandeh J. Curr Opin Struct Biol 45 74-84 (2017)
  62. Druggability of Voltage-Gated Sodium Channels-Exploring Old and New Drug Receptor Sites. Wisedchaisri G, Gamal El-Din TM. Front Pharmacol 13 858348 (2022)
  63. Interpreting the functional role of a novel interaction motif in prokaryotic sodium channels. Sula A, Wallace BA. J Gen Physiol 149 613-622 (2017)
  64. Global versus local mechanisms of temperature sensing in ion channels. Arrigoni C, Minor DL. Pflugers Arch 470 733-744 (2018)
  65. Cholesterol-Dependent Gating Effects on Ion Channels. Jiang QX. Adv Exp Med Biol 1115 167-190 (2019)
  66. Voltage gated sodium and calcium channels: Discovery, structure, function, and Pharmacology. Catterall WA. Channels (Austin) 17 2281714 (2023)
  67. Hydrophobic Drug/Toxin Binding Sites in Voltage-Dependent K+ and Na+ Channels. Van Theemsche KM, Van de Sande DV, Snyders DJ, Labro AJ. Front Pharmacol 11 735 (2020)
  68. Asymmetric perturbations of signalling oligomers. Maksay G, Tőke O. Prog Biophys Mol Biol 114 153-169 (2014)
  69. Nanosecond Pulsed Electric Field (nsPEF): Opening the Biotechnological Pandora's Box. Ruiz-Fernández AR, Campos L, Gutierrez-Maldonado SE, Núñez G, Villanelo F, Perez-Acle T. Int J Mol Sci 23 6158 (2022)
  70. Roles of Microglial Ion Channel in Neurodegenerative Diseases. Cojocaru A, Burada E, Bălșeanu AT, Deftu AF, Cătălin B, Popa-Wagner A, Osiac E. J Clin Med 10 1239 (2021)
  71. Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go? Li ZM, Chen LX, Li H. Curr Med Sci 39 863-873 (2019)
  72. Fenestropathy of Voltage-Gated Sodium Channels. Gamal El-Din TM, Lenaeus MJ. Front Pharmacol 13 842645 (2022)
  73. Comparison of permeation mechanisms in sodium-selective ion channels. Boiteux C, Flood E, Allen TW. Neurosci Lett 700 3-8 (2019)
  74. Theoretical and simulation studies on voltage-gated sodium channels. Li Y, Gong H. Protein Cell 6 413-422 (2015)
  75. Cryo-electron microscopy for structure analyses of membrane proteins in the lipid bilayer. Abe K, Fujiyoshi Y. Curr Opin Struct Biol 39 71-78 (2016)
  76. Modelling the interactions between animal venom peptides and membrane proteins. Hung A, Kuyucak S, Schroeder CI, Kaas Q. Neuropharmacology 127 20-31 (2017)
  77. Small molecule modulation of voltage gated sodium channels. Carnevale V, Klein ML. Curr Opin Struct Biol 43 156-162 (2017)
  78. Fifty years of gating currents and channel gating. Catacuzzeno L, Conti F, Franciolini F. J Gen Physiol 155 e202313380 (2023)
  79. When the Gates Swing Open Only: Arrhythmia Mutations That Target the Fast Inactivation Gate of Nav1.5. Gamal El-Din TM. Cells 11 3714 (2022)
  80. [Progress on structural biology of voltage-gated ion channels]. Song F, Guo J. Zhejiang Da Xue Xue Bao Yi Xue Ban 48 25-33 (2019)
  81. Conotoxins Targeting Voltage-Gated Sodium Ion Channels. Pei S, Wang N, Mei Z, Zhangsun D, Craik DJ, McIntosh JM, Zhu X, Luo S. Pharmacol Rev 76 828-845 (2024)

Articles citing this publication (181)



Quick links